Michelle Taylor¹, Leela Raju² and VK Raju³*

¹West Virginia School of Osteopathic Medicine, USA
²NYU Langone Eye Center, New York, USA
³Regional Eye Associates, Inc. and West Virginia University, USA

*Corresponding Author: VK Raju, Regional Eye Associates, Inc. and West Virginia University, USA.

Received: December 04, 2021; Published: April 06, 2022

Abstract

Temporal arteritis, also known as giant cell arteritis, is a disease that can affect both males and females over 50 years of age. Temporal arteritis may be uncommon, but it is not benign and may cause its victims to become irreversibly blind if the disease is not identified and treated promptly. Various symptoms may present in a slow and insidious manner, which can make the diagnosis initially less obvious. We present a patient who went to multiple physicians and was diagnosed with stress and occipital neuralgia before finally being correctly diagnosed with temporal arteritis.

Keywords: Temporal Arteritis; Giant Cell Arteritis; Blindness; Loss of Vision; Jaw Claudication; Jaw Pain; Headache; Weight Loss; Weakness; Erythrocyte Sedimentation Rate (ESR)

Bibliography

1. Tiosano S., et al. “Pericarditis among giant cell arteritis patients: from myth to reality”. Clinical Cardiology 41 (2018): 623-627.
2. Junejo S., et al. “Giant Cell (Temporal) Arteritis with persistent bilateral sensorineural hearing loss - a likely consequence of delayed institution of glucocorticoid therapy”. American Journal of Case Reports 18 (2017): 1233-1237.
3. Kuganesan T and Huang AR. “Stroke as an atypical initial presentation of giant cell arteritis”. BMC Geriatrics 1 (2018): 55.
4. Hassane HH., et al. “Co-Presentation of giant cell arteritis and granulomatosis with polyangiitis: a case report and review of literature”. American Journal of Case Reports 19 (2018): 651-655.
5. Truffaut L and Lefebvre P. “Tongue necrosis in Giant-Cell Arteritis”. New England Journal of Medicine 378 (2018): 2517.
6. Chandratilleke D., et al. “Migratory large vessel vasculitis preceding acute myeloid leukemia: a case report”. Journal of Medical Case Reports 11 (2017): 71.
7. Tokushige S., et al. “Hypertrophic Pachymeningitis as a Potential Cause of Headache Associated with Temporal Arteritis”. Internal Medicine5 (2016): 523-526.
8. Stanca HT., et al. “Giant cell arteritis with arteritic anterior ischemic optic neuropathy”. Romanian Journal of Morphology and Embryology1 (2017): 281-285.
9. de Worm S., et al. “A case of giant cell arteritis associated with culture-proven Coxiella burnetii aortitis”. International Journal of Infectious Diseases 69 (2018): 50-54.
10. Konishi C., et al. “Interstitial Lung Disease as an Initial Manifestation of Giant Cell Arteritis”. Internal Medicine19 (2017): 2633-2637.
11. Hsu YW., et al. “Orbital cellulitis presenting as giant cell arteritis: a case report”. Acta Neurologica Taiwanica2 (2017): 72-75.
12. Kellner C. “Erythrocyte Sedimentation Rate”. MedScape (2014).
13. Bernelot Moens HJ. “Temporal arteritis: do not rely on the erythrocyte sedimentation rate”. Dutch Journal of Medicine 159 (2015): A9196.
14. Singh R., et al. “New headaches with normal inflammatory markers: an early atypical presentation of giant cell arteritis”. BMJ Case Report (2018).
15. Watelet B., et al. “Treatment of giant-cell arteritis, a literature review”. Modern Rheumatology5 (2017): 747-754.
16. Samson M., et al. “Biological treatments in giant cell arteritis and Takayasu arteritis”. European Journal of Internal Medicine 50 (2018): 12-19.
17. Garrity ST., et al. “Ophthalmic presentation of giant cell arteritis in African-Americans”. Eye 31 (2017): 113-118.
18. Tian G., et al. “Giant cell arteritis presenting as bilateral anterior ischemic optic neuropathy: a biopsy-proven case report in Chinese patient”. BMC Ophthalmology 18 (2018): 282.

Citation: VK Raju., et al. “Temporal Arteritis: A Nearly Catastrophic Miss". Acta Scientific Clinical Case Reports 3.5 (2022): 15-17.

Copyright: © 2022 VK Raju., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.